Table 3.
Prevalence and control of hypertension in the population of the Tehran Cohort Study based on the 2017 ACC/AHA and 2018 ESC/ESH guidelines (n = 8296).
|
| ||
| 2018 ESC/ESH | 2017 ACC/AHA | |
|---|---|---|
|
| ||
| Hypertension, n (%)* | 3288 (39.8) | 5288 (64.0) |
|
| ||
| Age, mean (SD), year | 60.2 (12.16) | 56.8 (12.59) |
|
| ||
| Sex, n (%) | ||
|
| ||
| Men | 1500 (39.5) | 2447 (64.3) |
|
| ||
| Women | 1788 (40.1) | 2841 (63.7) |
|
| ||
| Control, n (%)# | 1328 (40.4) | 586 (11.1) |
|
| ||
| Age, mean (SD), year | 62.4 (11.09) | 63.8 (11.32) |
|
| ||
| Sex, n (%) | ||
|
| ||
| Men | 565 (37.7) | 254 (10.4) |
|
| ||
| Women | 763 (42.7) | 332 (11.7) |
|
| ||
| Control among treated, n (%)† | 1023 (58.4) | 467 (26.7) |
|
| ||
| Age, mean (SD), year | 63.2 (10.81) | 64.4 (11.00) |
|
| ||
| Sex, n (%) | ||
|
| ||
| Men | 451 (58.9) | 209 (27.3) |
|
| ||
| Women | 572 (58.0) | 258 (26.2) |
|
| ||
* Categorical data are reported as numbers (percentage in the row) for each subgroup.
# Percentages calculated from the hypertensive population (n = 3288).
† Percentages calculated from the treated population (n = 1752).